Mylan settles Detrol LA patent litigation
The litigation is related to Mylan Pharmaceuticals’ abbreviated new drug application (ANDA) for Tolterodine Tartrate ER capsules, 2mg and 4mg, the generic version of Pfizer’s Detrol LA, indicated
Vertex has signed a definitive agreement to purchase Crinetics Pharmaceuticals in a transaction valued at nearly $10bn, or $8.8bn net of estimated cash acquired.